SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000926617-20-000066
Filing Date
2020-09-18
Accepted
2020-09-18 17:07:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 awh-20200918xs3.htm S-3 289100
2 EX-5.1 awh-20200918xex5_1.htm EX-5.1 18471
3 EX-23.1 awh-20200918xex23_1.htm EX-23.1 6930
4 GRAPHIC awh-20200918xex5_1g001.jpg GRAPHIC 16434
5 GRAPHIC awh-20200918xs3g001.jpg GRAPHIC 33590
  Complete submission text file 0000926617-20-000066.txt   385011
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-248920 | Film No.: 201184624
SIC: 2835 In Vitro & In Vivo Diagnostic Substances